- Markets
- Healthcare
- ADLINE
ADLINE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Adline Chem Lab do?
Founded in 1990 in Ahmedabad, Kamron Laboratories Ltd produces tablets, capsules, and liquid orals. They aim to establish strong brands and be among top three in their segments and countries of operation.
Who are the competitors of Adline Chem Lab?
Adline Chem Lab major competitors are MPS Pharmaa, Fabino Enterprises, Shamrock Indl. Co, Ganga Pharma., Kobo Biotech, Zyden Gentec, Senbo Industries. Market Cap of Adline Chem Lab is ₹6 Crs. While the median market cap of its peers are ₹6 Crs.
Is Adline Chem Lab financially stable compared to its competitors?
Adline Chem Lab seems to be less financially stable compared to its competitors. Altman Z score of Adline Chem Lab is 0 and is ranked 4 out of its 8 competitors.
Does Adline Chem Lab pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Adline Chem Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Adline Chem Lab allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Adline Chem Lab balance sheet?
Adline Chem Lab balance sheet is weak and might have solvency issues
Is the profitablity of Adline Chem Lab improving?
The profit is oscillating. The profit of Adline Chem Lab is -₹0.15 Crs for Mar 2024, -₹4.23 Crs for Mar 2023 and ₹0.72 Crs for Mar 2022
Is the debt of Adline Chem Lab increasing or decreasing?
Yes, The debt of Adline Chem Lab is increasing. Latest debt of Adline Chem Lab is ₹1.54 Crs as of Sep-24. This is greater than Mar-24 when it was ₹1.44 Crs.
Is Adline Chem Lab stock expensive?
Adline Chem Lab is not expensive. Latest PE of Adline Chem Lab is 0.0, while 3 year average PE is 171. Also latest EV/EBITDA of Adline Chem Lab is 0.0 while 3yr average is 5.89.
Has the share price of Adline Chem Lab grown faster than its competition?
Adline Chem Lab has given better returns compared to its competitors. Adline Chem Lab has grown at ~12.79% over the last 3yrs while peers have grown at a median rate of 0.0%
Is the promoter bullish about Adline Chem Lab?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Adline Chem Lab is 29.61% and last quarter promoter holding is 29.61%.
Are mutual funds buying/selling Adline Chem Lab?
There is Insufficient data to gauge this.